GEn1E gains rights to MUC1 IP

GEn1E Lifesciences Inc. (Palo Alto, Calif.) gained an exclusive option to license patent rights to mucin 1 (MUC1; CD227) decoy peptides from the University of Maryland Baltimore (Baltimore, Md.) to treat and prevent bacterial infections. ...